Related Experiment Video
Updated: Jul 19, 2026

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
Published on: November 30, 2013
Identification of necroptosis-associated mRNA biomarkers in kidney clear cell carcinoma
Xiaobo Zhang1, Qiaoying Jin1, Gafang Cheng1
1Cuiying Biomedical Research Center, The Second Hospital & Clinical Medicine School, Lanzhou University, Lanzhou, China.
Introduction:
Kidney clear cell carcinoma (KIRC) is the most common subtype of renal malignancy with a high mortality rate. It is difficult to treat and often leads to death due to its genomic heterogeneity, metastatic nature, and limited effectiveness of targeted and immunotherapies. Recent studies showed that the progression of KIRC is frequently accompanied by significant changes in necroptosis while these studies were limited by small gene sets, which increases the risk of missing low-expressed yet important genes.
Methods:
This study focused on necroptosis-associated genes within the context of KIRC and performed a complete closed-loop studies by gene screening, gene expression analysis, model validation and experimental translation.
Results:
Among screened nine core biomarkers (RIPK1, RIPK3, MLKL, CASP8, ZBP1, TLR3, PYGL, TRPM7, PGAM5), CASP8 and TRPM7 were identified as new potential biomarkers. The predictive performance of risk prognostic model for 5-year survival (AUC: 0.77 and 0.89 in training and independent/external validation cohort) outperformed prior studies by 5.5% and 17.1%, respectively. A more pronounced immune response was found with high-risk cohort, underscoring the immunosuppressive properties of tumor immune microenvironments, which evidenced by increased immune cell infiltration and elevated immunogenicity. Drug sensitivity analysis revealed that doxorubicin could serve as a promising therapeutic agent for KIRC. Furthermore, BFTC909 and CAL54 were identified as the most suitable cell lines for in vitro experimental translation, and highlighting three functionally significant target genes (CASP8, PGAM5, and CPT2).
Conclusion:
This study offers multi-dimensional data that support novel mechanistic investigations and provide valuable insights for developing precision immunotherapy strategies in KIRC.
Insights
This study identifies new necroptosis-associated biomarkers, CASP8 and TRPM7, for kidney clear cell carcinoma (KIRC). A novel prognostic model improves survival prediction and suggests doxorubicin as a potential treatment for KIRC patients.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Kidney clear cell carcinoma (KIRC) presents high mortality due to genomic heterogeneity and treatment resistance.
- Necroptosis pathway alterations are implicated in KIRC progression, but previous studies used limited gene sets.
- Identifying novel biomarkers is crucial for improving KIRC diagnosis and treatment strategies.
Purpose of the Study:
- To identify and validate novel necroptosis-associated genes as biomarkers for KIRC.
- To develop and assess a prognostic model for KIRC patient survival.
- To explore potential therapeutic strategies and experimental models for KIRC.
Main Methods:
- Comprehensive screening of necroptosis-associated genes in KIRC.
- Gene expression analysis and validation of core biomarkers.
- Development and performance evaluation of a 5-year survival prognostic model.
- Analysis of tumor immune microenvironment and drug sensitivity.
- Identification of suitable cell lines for in vitro experimental translation.
Main Results:
- Nine core biomarkers were screened, with CASP8 and TRPM7 identified as novel potential biomarkers.
- The developed prognostic model demonstrated superior predictive performance for 5-year survival (AUC 0.77-0.89).
- High-risk patients exhibited pronounced immune responses and immunosuppressive tumor microenvironments.
- Doxorubicin was identified as a promising therapeutic agent for KIRC.
- BFTC909 and CAL54 cell lines were suitable for in vitro studies, highlighting CASP8, PGAM5, and CPT2.
Conclusions:
- This study provides novel necroptosis-associated biomarkers and a validated prognostic model for KIRC.
- Findings offer insights into KIRC's immune microenvironment and potential therapeutic targets.
- The results support the development of precision immunotherapy strategies for KIRC.
Related Concept Videos
MicroRNAs
Nuclear Export of mRNA
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
MicroRNAs

